Selective inhibition of the hypoxia-inducible factor prolyl hydroxylase PHD3 by Zn(II)

被引：2
|
作者：
Na, Yu-Ran [1 ,2 ]
Woo, Dustin J. [1 ,3 ]
Choo, Hyunah [3 ,4 ]
Chung, Hak Suk [1 ,3 ]
Yang, Eun Gyeong [1 ,3 ]
机构：
[1] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Seoul 136791, South Korea
[2] Korea Univ, Res Inst Nat Sci, Dept Chem, Seoul 136701, South Korea
[3] Korea Univ Sci & Technol UST, Dept Biol Chem, Seoul 136791, South Korea
[4] Korea Inst Sci & Technol, Ctr Neuromed, Brain Sci Inst, Seoul 136791, South Korea
来源：
CHEMICAL COMMUNICATIONS | 2015年 / 51卷 / 53期
关键词：
ERYTHROPOIETIN GENE; HIF-ALPHA; FACTOR-I; BINDING; DESFERRIOXAMINE; COPPER;
D O I：
10.1039/c5cc02143j
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
We report herein that Zn(II) selectively inhibits the hypoxia- inducible factor prolyl hydroxylase PHD3 over PHD2, and does not compete with Fe(II). Independent of the oligomer formation induced by Zn(II), inhibition of the activity of PHD3 by Zn(II) involves Cys42 and Cys52 residues distantly located from the active site.
引用
收藏
页码：10730 / 10733
页数：4
相关论文
共 50 条
  • [11] Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma
    Miikkulainen, Petra
    Hogel, Heidi
    Seyednasrollah, Fatemeh
    Rantanen, Krista
    Elo, Laura L.
    Jaakkola, Panu M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (10) : 3760 - 3771
  • [12] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors and Iron Metabolism
    Ogawa, Chie
    Tsuchiya, Ken
    Maeda, Kunimi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [13] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in CKD
    Parfrey, Patrick
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (25): : 2390 - 2391
  • [14] Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
    Ivan, M
    Haberberger, T
    Gervasi, DC
    Michelson, KS
    Günzler, V
    Kondo, K
    Yang, HF
    Sorokina, I
    Conaway, RC
    Conaway, JW
    Kaelin, WG
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) : 13459 - 13464
  • [15] Cellular oxygen sensing:: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)
    McDonough, Michael A.
    Li, Vivian
    Flashman, Emily
    Chowdhury, Rasheduzzaman
    Mohr, Christopher
    Lienard, Benoit M. R.
    Zondlo, James
    Oldham, Neil J.
    Clifton, Ian J.
    Lewis, Jeffrey
    McNeill, Luke A.
    Kurzeja, Robert J. M.
    Hewitson, Kirsty S.
    Yang, Evelyn
    Jordan, Steven
    Syed, Rashid S.
    Schofield, Christopher J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (26) : 9814 - 9819
  • [16] Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27
    Hoegel, Heidi
    Miikkulainen, Petra
    Bino, Lucia
    Jaakkola, Panu M.
    MOLECULAR CANCER, 2015, 14
  • [17] Hypoxia-inducible factor prolyl hydroxylase enzyme inhibitors: ready for primetime?
    Macdougall, Iain C.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2022, 31 (05): : 399 - 405
  • [18] Hypoxia inducible prolyl hydroxylase PHD3 maintains carcinoma cell growth by decreasing the stability of p27
    Heidi Högel
    Petra Miikkulainen
    Lucia Bino
    Panu M. Jaakkola
    Molecular Cancer, 14
  • [19] Hypoxia-inducible factor prolyl hydroxylase domain (PHD) inhibition after contusive spinal cord injury does not improve locomotor recovery
    Wei, George Z.
    Saraswat Ohri, Sujata
    Khattar, Nicolas K.
    Listerman, Adam W.
    Doyle, Catherine H.
    Andres, Kariena R.
    Karuppagounder, Saravanan S.
    Ratan, Rajiv R.
    Whittemore, Scott R.
    Hetman, Michal
    PLOS ONE, 2021, 16 (04):
  • [20] FDA approves first hypoxia-inducible factor prolyl hydroxylase inhibitor
    Asher Mullard
    Nature Reviews Drug Discovery, 2023, 22 : 173 - 173
12345